Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Continue reading →
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort 16 Jul Continue reading →
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis. 28 May Continue reading →
Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress Continue reading →
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. 22 Nov Continue reading →
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. 22 Nov Continue reading →
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis. 22 Nov Continue reading →
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation. 22 Nov Continue reading →